<VariationArchive RecordType="classified" VariationID="1695356" VariationName="NM_000552.5(VWF):c.1318del (p.Cys440fs)" VariationType="Deletion" Accession="VCV001695356" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-07-18" MostRecentSubmission="2022-07-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1687783" VariationID="1695356">
      <GeneList>
        <Gene Symbol="VWF" FullName="von Willebrand factor" GeneID="7450" HGNC_ID="HGNC:12726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="5948877" stop="6124670" display_start="5948877" display_stop="6124670" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6058039" stop="6233835" display_start="6058039" display_stop="6233835" Strand="-" />
          </Location>
          <OMIM>613160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000552.5(VWF):c.1318del (p.Cys440fs)</Name>
      <CanonicalSPDI>NC_000012.12:6064359:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6064360" stop="6064360" display_start="6064360" display_stop="6064360" variantLength="1" positionVCF="6064359" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6173526" stop="6173526" display_start="6173526" display_stop="6173526" variantLength="1" positionVCF="6173525" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>p.C440A fs*17</Name>
      </OtherNameList>
      <ProteinChange>C440fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.6173526del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.6173526del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.6064360del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.6064360del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009072.2" sequenceAccession="NG_009072" sequenceVersion="2" change="g.65311del">
            <Expression>NG_009072.2:g.65311del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.5" sequenceAccession="NM_000552" sequenceVersion="5" change="c.1318del" MANESelect="true">
            <Expression>NM_000552.5:c.1318del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000543.3" sequenceAccession="NP_000543" sequenceVersion="3" change="p.Cys440fs">
            <Expression>NP_000543.3:p.Cys440fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_587" sequenceAccession="LRG_587">
            <Expression>LRG_587:g.65311del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_587t1" sequenceAccession="LRG_587t1">
            <Expression>LRG_587t1:c.1318del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_587p1" sequenceAccession="LRG_587p1" change="p.Cys440fs">
            <Expression>LRG_587p1:p.Cys440fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2136462110" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000552.5(VWF):c.1318del (p.Cys440fs) AND von Willebrand disease type 1" Accession="RCV002264859" Version="1">
        <ClassifiedConditionList TraitSetID="88">
          <ClassifiedCondition DB="MedGen" ID="C1264039">von Willebrand disease type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-12-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-12-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-07-18" MostRecentSubmission="2022-07-18">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="88" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9626" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE I</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VWD, TYPE 1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 1</ElementValue>
                <XRef ID="von+Willebrand+disease%2C+type+1/9460" DB="Genetic Alliance" />
                <XRef ID="128106003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17019" />
                <XRef ID="17019" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">autosomal recessive or autosomal dominant</Attribute>
                <XRef ID="GTR000502548" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083611</ID>
              </Citation>
              <XRef ID="166078" DB="Orphanet" />
              <XRef ID="903" DB="Orphanet" />
              <XRef ID="C1264039" DB="MedGen" />
              <XRef ID="MONDO:0008668" DB="MONDO" />
              <XRef Type="MIM" ID="193400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4984699" SubmissionDate="2022-06-24" DateLastUpdated="2022-07-18" DateCreated="2022-07-18">
        <ClinVarSubmissionID localKey="NM_000552.3:c.1318delT|OMIM:193400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002546309" DateUpdated="2022-07-18" DateCreated="2022-07-18" Type="SCV" Version="1" SubmitterName="Laboratory of Hematology, Radboud University Medical Center" OrgID="508621" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.C440A fs*17</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.1318delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="193400" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>WIN study</StudyName>
        <StudyDescription>The Willebrand in the Netherlands study aims to register and investigate all patients in the Netherlands with moderate and severe von Willebrand Disease to assess clinical presentation, treatment and related complications of treatment.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>WIN study</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4984699" TraitType="Disease" MappingType="XRef" MappingValue="193400" MappingRef="OMIM">
        <MedGen CUI="C1264039" Name="von Willebrand disease type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

